Clinical utility of Thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC)

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 12, 2011, Pages 3615-3627

  Spencer, Carole A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; TUMOR MARKER; AUTOANTIBODY; THYROGLOBULIN;

ANTIBODY BLOOD LEVEL; CANCER RISK; DIFFERENTIATED THYROID CANCER; DISEASE ASSOCIATION; DISEASE MARKER; FALSE NEGATIVE RESULT; HASHIMOTO DISEASE; HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; PROGNOSIS; RADIOIMMUNOASSAY; RELIABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; THYROID PAPILLARY CARCINOMA; BLOOD; IMMUNOLOGY; THYROID TUMOR;

AUTOANTIBODIES; HASHIMOTO DISEASE; HUMANS; THYROGLOBULIN; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 83155192290     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1740     Document Type: Review

References (126)

1. Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214
2. Kumar A, Shah DH, Shrihari U, Dandekar SR, Vijayan U, Sharma SM 1994 Significance of antithyroglobulin autoantibodies in differentiated thyroid carcinoma. Thyroid 4:199-202 (Pubitemid 24202356)
3. Souza SL, Montalli Da Assumpção LV, Ward LS 2003 Impact of previous thyroid autoimmune diseases on prognosis of patients with well-differentiated thyroid cancer. Thyroid 13:491-495
4. Pacini F, Mariotti S, Formica N, Elisei R, Anelli S, Capotorti E, Pinchera A 1988 Thyroid autoantibodies in thyroid cancer: incidence and relationship with tumor outcome. Acta Endocrinol 119: 373-380
5. Spencer CA, Takeuchi M, Kazarosyan M, Wang CC, Guttler RB, Singer PA, Fatemi S, LoPresti JS, Nicoloff JT 1998 Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 83:1121-1127 (Pubitemid 28496379)
6. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE 2002 Serum thyrotropin, thyroxine, and thyroid antibodies in the United States population (1988 to 1994): NHANES III. J Clin Endocrinol Metab 87:489-499 (Pubitemid 34158210)
7. Chung JK, Park YJ, Kim TY, So Y, Kim SK, Park DJ, Lee DS, Lee MC, Cho BY 2002 Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation. Clin Endocrinol (Oxf) 57:215-221 (Pubitemid 34989098)
8. Görges R, Maniecki M, Jentzen W, Sheu SN, Mann K, Bockisch A, Janssen OE 2005 Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy. Eur J Endocrinol 153:49-55 (Pubitemid 41030515)
9. Feldt-Rasmussen U, Rasmussen AK 2010 Autoimmunity in differentiated thyroid cancer: significance and related clinical problems. Hormones (Athens) 9:109-117
10. Dailey ME, Lindsay S, Skahen R 1955 Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland.AMAArch Surg 70:291-297
11. Schlicke CP, Hill JE, Schultz GF 1960 Carcinoma in chronic thyroiditis. Surg Gynecol Obstet 111:552-556
12. Hirabayashi RN, Lindsay S 1965 The relation of thyroid carcinoma and chronic thyroiditis. Surg Gynecol Obstet 121:243-252
13. Ott RA, McCall AR, McHenry C, Jarosz H, Armin A, Lawrence AM, Paloyan E 1987 The incidence of thyroid carcinoma in Hashimoto's thyroiditis. Am Surg 53:442-445 (Pubitemid 17122376)
14. Kurukahvecioglu O, Taneri F, Yüksel O, Aydin A, Tezel E, Onuk E 2007 Total thyroidectomy for the treatment of Hashimoto's thyroiditis coexisting with papillary thyroid carcinoma. Adv Ther 24: 510-516 (Pubitemid 47295427)
15. Repplinger D, Bargren A, Zhang YW, Adler JT, Haymart M, Chen H 2008 Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer. J Surg Res 150:49-52
16. Gul K, Dirikoc A, Kiyak G, Ersoy PE, Ugras NS, Ersoy R, Cakir B 2010 The association between thyroid carcinoma and Hashimoto's thyroiditis: the ultrasonographic and histopathologic characteristics of malignant nodules. Thyroid 20:873-878
17. Consorti F, Loponte M, Milazzo F, Potasso L, Antonaci A 2010 Risk of malignancy from thyroid nodular disease as an element of clinical management of patients with Hashimoto's thyroiditis. Eur Surg Res 45:333-337
18. Wirtschafter A, Schmidt R, Rosen D, Kundu N, Santoro M, Fusco A, Multhaupt H, Atkins JP, Rosen MR, Keane WM, Rothstein JL 1997 Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope 107:95-100 (Pubitemid 27045201)
19. Arif S, Blanes A, Diaz-Cano SJ 2002 Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma. Histopathology 41:357-362 (Pubitemid 35279034)
20. Unger P, Ewart M, Wang BY, Gan L, Kohtz DS, Burstein DE 2003 Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link. Hum Pathol 34:764-769 (Pubitemid 37040611)
21. Rhoden KJ, Unger K, Salvatore G, Yilmaz Y, Vovk V, Chiappetta G, Qumsiyeh MB, Rothstein JL, Fusco A, Santoro M, Zitzelsberger H, Tallini G 2006 RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma. J Clin Endocrinol Metab 91:2414-2423 (Pubitemid 43855035)
22. Larson SD, Jackson LN, Riall TS, Uchida T, Thomas RP, Qiu S, Evers BM 2007 Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg 204:764-775
23. Kang DY, Kim KH, Kim JM, Kim SH, Kim JY, Baik HW, Kim YS 2007 High prevalence of RET, RAS, and ERK expression in Hashimoto's thyroiditis and in papillary thyroid carcinoma in the Korean population. Thyroid 17:1031-1038
24. Antonaci A, Consorti F, Mardente S, Giovannone G 2009 Clinical and biological relationship between chronic lymphocytic thyroiditis and papillary thyroid carcinoma. Oncol Res 17:495-503
25. Muzza M, Degl'Innocenti D, Colombo C, Perrino M, Ravasi E, Rossi S, Cirello V, Beck-Peccoz P, Borrello MG, Fugazzola L 2010 The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol (Oxf) 72:702-708
26. Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC, Franklyn JA 2006 Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 91:4295-4301 (Pubitemid 44833401)
27. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, Chen H 2008 Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 93:809-814 (Pubitemid 351398557)
28. Kim HS, Choi YJ, Yun JS 2010 Features of papillary thyroid microcarcinoma in the presence and absence of lymphocytic thyroiditis. Endocr Pathol 21:149-153
29. Fiore E, Rago T, Latrofa F, Provenzale MA, Piaggi P, Delitala A, Scutari M, Basolo F, Di Coscio G, Grasso L, Pinchera A, Vitti P 2011 Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine. Endocr Relat Cancer 18:429-437
30. Kim KW, Park YJ, Kim EH, Park SY, Park do J, Ahn SH, Park do J, Jang HC, Cho BY 2011 Elevated risk of papillary thyroid cancer in Korean patients with Hashimoto's thyroiditis. Head Neck 33:691-695
31. Balkwill F, Mantovani A 2001 Inflammation and cancer: back to Virchow? Lancet 357:539-545 (Pubitemid 32173595)
32. McLachlan SM, Rapoport B 2004 Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies. Thyroid 14:510-520 (Pubitemid 39014589)
33. Boi F, Lai ML, Marziani B, Minerba L, Faa G, Mariotti S 2005 High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies. Eur J Endocrinol 153: 637-642 (Pubitemid 41672409)
34. de Visser KE, Eichten A, Coussens LM 2006 Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6:24-37 (Pubitemid 43053650)
35. Guarino V, Castellone MD, Avilla E, Melillo RM 2010 Thyroid cancer and inflammation. Mol Cell Endocrinol 321:94-102
36. Rebuffat SA, Morin M, Nguyen B, Castex F, Robert B, Péraldi-Roux S 2010 Human recombinant anti-thyroperoxidase autoantibodies: in vitro cytotoxic activity on papillary thyroid cancer expressing TPO. Br J Cancer 102:852-861
37. Mariotti S, Barbesino G, Caturegli P, Marinó M, Manetti L, Pacini F, Centoni R, Pinchera A 1995 Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal? J Clin Endocrinol Metab 80:468-472
38. Baloch Z, Carayon P, Conte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF, LiVosli VA, Niccoli-Sire P, John R, Ruf J, Smyth PP, Spencer CA, Stockigt JR 2003 Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:57-67
39. Spencer CA, Bergoglio LM, Kazarosyan M, Fatemi S, LoPresti JS 2005 Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 90:5566-5575 (Pubitemid 41415459)
40. Seo JH, Lee SW, Ahn BC, Lee J 2010 Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using (18)F-FDG PET/CT. Clin Endocrinol (Oxf) 72:558-563
41. Kim ES, Lim DJ, Baek KH, Lee JM, Kim MK, Kwon HS, Song KH, Kang MI, Cha BY, Lee KW, Son HY 2010 Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid 20:885-891
42. Spencer C, Petrovic I, Fatemi S 2011 Current thyroglobulin auto-antibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J Clin Endocrinol Metab 96:1283-1291
43. Adil A, Jafri RA, Waqar A, Abbasi SA, Matiul-Haq, Asghar AH, Jilani A, Naz I 2003 Frequency and clinical importance of anti-Tg auto-antibodies (ATG). J Coll Physicians Surg Pak 13:504-506 (Pubitemid 37279385)
44. Chiovato L, Latrofa F, Braverman LE, Pacini F, Capezzone M, Masserini L, Grasso L, Pinchera A 2003 Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann Intern Med 139:346-351
45. Rosário PW, Maia FF, Fagundes TA, Vasconcelos FP, Cardoso LD, Purisch S 2004 Antithyroglobulin antibodies in patients with differentiated thyroid carcinoma: methods of detection, interference with serum thyroglobulin measurement and clinical significance. Arq Bras Endocrinol Metabol 48:487-492
46. Küçük ON, Aras G, Kulak HA, Ibiş E 2006 Clinical importance of anti-thyroglobulin auto-antibodies in patients with differentiated thyroid carcinoma: comparison with 99mTc-MIBI scans. Nucl Med Commun 27:873-876 (Pubitemid 44526725)
47. Thomas D, Liakos V, Vassiliou E, Hatzimarkou F, Tsatsoulis A, Kaldrimides P 2007 Possible reasons for different pattern disappearance of thyroglobulin and thyroid peroxidase autoantibodies in patients with differentiated thyroid carcinoma following total thyroidectomy and iodine-131 ablation. J Endocrinol Invest 30: 173-180 (Pubitemid 46929314)
48. Kim WG, Yoon JH, Kim WB, Kim TY, Kim EY, Kim JM, Ryu JS, Gong G, Hong SJ, Shong YK 2008 Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 93:4683-4689
49. Black EG, Hoffenberg R 1983 Should one measure serum thyroglobulin in the presence of anti-thyroglobulin antibodies? Clin Endocrinol (Oxf) 19:597-601 (Pubitemid 14225998)
50. Stanojevic M, Savin S, Cvejic D, Djukic A, Jeremic M, ZivanceviæSimonovic S 2009 Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients. J Clin Lab Anal 23:341-346
51. Schneider AB, Pervos R 1978 Radioimmunoassay of human thyroglobulin: effect of antithyroglobulin autoantibodies. J Clin Endocrinol Metab 47:126-137 (Pubitemid 8371253)
52. Feldt-Rasmussen U, Rasmussen AK 1985 Serum thyroglobulin (Tg) in presence of thyroglobulin autoantibodies (TgAb). Clinical and methodological relevance of the interaction between Tg and TgAb in vitro and in vivo. J Endocrinol Invest 8:571-576 (Pubitemid 16135454)
53. Schaadt B, Feldt-Rasmussen U, Rasmusson B, Tørring H, Foder B, Jørgensen K, Hansen HS 1995 Assessment of the influence of thyroglobulin (Tg) autoantibodies and other interfering factors on the use of serum Tg as tumor marker in differentiated thyroid carcinoma. Thyroid 5:165-170
54. Spencer CA, Takeuchi M, KazarosyanM1996 Current status and performance goals for serum thyroglobulin assays. Clin Chem 42:164-173 (Pubitemid 26030404)
55. Weightman DR, Mallick UK, Fenwick JD, Perros P 2003 Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up. Cancer 98:41-47 (Pubitemid 36741123)
56. Okosieme OE, Evans C, Moss L, Parkes AB, Premawardhana LD, Lazarus JH 2005 Thyroglobulin antibodies in serum of patients with differentiated thyroid cancer: relationship between epitope specificities and thyroglobulin recovery. Clin Chem 51:729-734 (Pubitemid 40463924)
57. La'ulu SL, Slev PR, Roberts WL 2007 Performance characteristics of 5 automated thyroglobulin autoantibody and thyroid peroxidase autoantibody assays. Clin Chim Acta 376:88-95 (Pubitemid 44880984)
58. Cunha LL, Ferreira RC, Marcello MA, Vassallo J, Ward LS 2011 Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer. J Thyroid Res 2011:387062
59. Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP 1999 Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 84:458-463 (Pubitemid 29075669)
60. Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP 1999 Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 126:1070-1076; discussion 1076-1077
61. Tamimi DM 2002 The association between chronic lymphocytic thyroiditis and thyroid tumors. Int J Surg Pathol 10:141-146 (Pubitemid 34655100)
62. Cipolla C, Sandonato L, Graceffa G, Fricano S, Torcivia A, Vieni S, Latteri S, Latteri MA 2005 Hashimoto thyroiditis coexistent with papillary thyroid carcinoma. Am Surg 71:874-878
63. Anil C, Goksel S, Gursoy A 2010 Hashimoto's thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study. Thyroid 20:601-606
64. Grebe SK 2010 Thyroglobulin autoantibodies, thyroid nodules, and new insights into some old questions. Thyroid 20:841-842
65. Mazokopakis EE, Tzortzinis AA, Dalieraki-Ott EI, Tsartsalis AN, Syros PK, Karefilakis CM, Papadomanolaki MG, Starakis IK 2010 Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma. A retrospective study. Hormones (Athens) 9:312-317
66. Kebebew E, Treseler PA, Ituarte PH, Clark OH 2001 Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg 25:632-637 (Pubitemid 32441438)
67. Fiore E, Rago T, Scutari M, Ugolini C, Proietti A, Di Coscio G, Provenzale MA, Berti P, Grasso L, Mariotti S, Pinchera A, Vitti P 2009 Papillary thyroid cancer, although strongly associated with lymphocytic infiltration on histology, is only weakly predicted by serum thyroid auto-antibodies in patients with nodular thyroid diseases. J Endocrinol Invest 32:344-351
68. Tozzoli R, Bizzaro N, Tonutti E, Pradella M, Manoni F, Vilalta D, Bassetti D, Piazza A, Rizzotti P 2002 Immunoassay of anti-thyroid autoantibodies: high analytical variability in second generation methods. Clin Chem Lab Med 40:568-573 (Pubitemid 34855122)
69. Krahn J, DembinskiT2009 Thyroglobulin and anti-thyroglobulin assays in thyroid cancer monitoring. Clin Biochem 42:416-419
70. Kashima K, Yokoyama S, Noguchi S, Murakami N, Yamashita H, Watanabe S, Uchino S, Toda M, Sasaki A, Daa T, Nakayama I 1998 Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid 8:197-202 (Pubitemid 28145182)
71. Ugolini C, Basolo F, Proietti A, Vitti P, Elisei R, Miccoli P, Toniolo A 2007 Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma. Thyroid 17:389-393 (Pubitemid 46878841)
72. Segal K, Ben-Bassat M, Avraham A, Har-El G, Sidi J 1985 Hashimoto's thyroiditis and carcinoma of the thyroid gland. Int Surg 70:205-209 (Pubitemid 16131950)
73. Matsubayashi S, Kawai K, Matsumoto Y, Mukuta T, Morita T, Hirai K, Matsuzuka F, Kakudoh K, Kuma K, Tamai H 1995 The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab 80:3421-3424 (Pubitemid 3019478)
74. Ozaki O, Ito K, Mimura T, Sugino K, Hosoda Y 1996 Papillary carcinoma of the thyroid. Tall-cell variant with extensive lymphocyte infiltration. Am J Surg Pathol 20:695-698 (Pubitemid 26147466)
75. Schäffler A, Palitzsch KD, Seiffarth C, Höhne HM, Riedhammer FJ, Hofstädter F, Schölmerich J, Rüschoff J 1998 Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma. Eur J Clin Invest 28:838-844 (Pubitemid 28488118)
76. Gupta S, Patel A, Folstad A, Fenton C, Dinauer CA, Tuttle RM, Conran R, Francis GL 2001 Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults. J Clin Endocrinol Metab 86:1346-1354 (Pubitemid 32323027)
77. Kim EY, Kim WG, Kim WB, Kim TY, Kim JM, Ryu JS, Hong SJ, Gong G, Shong YK 2009 Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol (Oxf) 71:581-586
78. Kim KH, Suh KS, Kang DW, Kang DY 2005 Mutations of the BRAF gene in papillary thyroid carcinoma and in Hashimoto's thyroiditis. Pathol Int 55:540-545
79. Sargent R, LiVolsi V, Murphy J, Mantha G, Hunt JL 2006 BRAF mutation is unusual in chronic lymphocytic thyroiditis-associated papillary thyroid carcinomas and absent in non-neoplastic nuclear atypia of thyroiditis. Endocr Pathol 17:235-241
80. Kim SK, Song KH, Lim SD, Lim YC, Yoo YB, Kim JS, Hwang TS 2009 Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis. Thyroid 19:137-141
81. Basolo F, Torregrossa L, Giannini R, Miccoli M, Lupi C, Sensi E, Berti P, Elisei R, Vitti P, Baggiani A, Miccoli P 2010 Correlation between the BRAFV600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases. J Clin Endocrinol Metab 95:4197-4205
82. Asanuma K, Sugenoya A, Kasuga Y, Itoh N, Kobayashi S, Amano J 1998 The relationship between multiple intrathyroidal involvement in papillary thyroid carcinoma and chronic non-specific thyroiditis. Cancer Lett 122:177-180 (Pubitemid 28058633)
83. Hjiyiannakis P, Mundy J, Harmer C 1999 Thyroglobulin antibodies in differentiated thyroid cancer. Clin Oncol (R Coll Radiol) 11:240-244 (Pubitemid 29425755)
84. Nordyke RA, Gilbert Jr FI, Miyamoto LA, Fleury KA 1993 The superiority of antimicrosomal over antithyroglobulin antibodies for detecting Hashimoto's thyroiditis. Arch Intern Med 153:862-865 (Pubitemid 23118026)
85. Chen CR, Hamidi S, Braley-Mullen H, Nagayama Y, Bresee C, Aliesky HA, Rapoport B, McLachlan SM 2010 Antibodies to thyroid peroxidase arise spontaneously with age in NOD.H-2h4 mice and appear after thyroglobulin antibodies. Endocrinology 151:4583-4593
86. Latrofa F, Ricci D, Grasso L, Vitti P, Masserini L, Basolo F, Ugolini C, Mascia G, Lucacchini A, Pinchera A 2008 Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies. J Clin Endocrinol Metab 93:591-596 (Pubitemid 351246677)
87. Heilig B, Hüfner M, Dörken B, Schmidt-Gayk H 1986 Increased heterogeneity of serum thyroglobulin in thyroid cancer patients as determined by monoclonal antibodies. Klin Wochenschr 64:776-780 (Pubitemid 16044196)
88. Magro G, Perissinotto D, Schiappacassi M, Goletz S, Otto A, Müller EC, Bisceglia M, Brown G, Ellis T, Grasso S, Colombatti A, Perris R 2003 Proteomic and postproteomic characterization of keratan sulfate-glycanated isoforms of thyroglobulin and transferrin uniquely elaborated by papillary thyroid carcinomas. Am J Pathol 163:183-196 (Pubitemid 36759603)
89. Cubero JM, Rodríguez-Espinosa J, Gelpi C, Estorch M, Corcoy R 2003 Thyroglobulin autoantibody levels below the cut-off for positivity can interfere with thyroglobulin measurement. Thyroid 13:659-661 (Pubitemid 36993562)
90. Weetman AP, McGregor AM 1994 Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 15:788-830
91. Luboshitzky R, Lavi I, Ishay A 2006 Serum thyroglobulin levels after fine-needle aspiration of thyroid nodules. Endocr Pract 12:264-269
92. Polyzos SA, Anastasilakis AD 2010 Alterations in serum thyroid-related constituents after thyroid fine-needle biopsy: a systematic review. Thyroid 20:265-271
93. Feldt-Rasmussen U, Petersen PH, Date J, Madsen CM 1980 Sequential changes in serum thyroglobulin (Tg) and its autoantibodies (TgAb) following subtotal thyroidectomy of patients with preoperatively detectable TgAb. Clin Endocrinol (Oxf) 12:29-38 (Pubitemid 10174979)
94. Bech K, Feldt-Rasmussen U, Bliddal H, Date J, Blichert-Toft M 1982 The acute changes in thyroid stimulating immunoglobulins, thyroglobulin and thyroglobulin antibodies following subtotal thyroidectomy. Clin Endocrinol (Oxf) 16:235-242 (Pubitemid 12168202)
95. Feldt-Rasmussen U 1983 Serum thyroglobulin and thyroglobulin autoantibodies in thyroid diseases. Pathogenetic and diagnostic aspects. Allergy 38:369-387
96. Weigle WO, High GJ 1967 The behaviour of autologous thyroglobulin in the circulation of rabbits immunized with either heterologous or altered homologous thyroglobulin. J Immunol 98:1105-1114
97. Feldt-Rasmussen U, Blichert-Toft M, Christiansen C, Date J 1982 Serum thyroglobulin and its autoantibody following subtotal thyroid resection of Graves' disease. Eur J Clin Invest 12:203-208 (Pubitemid 12082473)
98. Izumi M, Larsen PR 1978 Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis. Metabolism 27:449-460 (Pubitemid 8303648)
99. Uller RP, Van Herle AJ 1978 Effect of therapy on serum thyroglobulin levels in patients with Graves' disease. J Clin Endocrinol Metab 46:747-755 (Pubitemid 8345866)
100. Feldt-Rasmussen U, Bech K, Date J, Petersen PH, Johansen K 1982 A prospective study of the differential changes in serum thyroglobulin and its autoantibodies during propylthiouracil or radioiodine therapy of patients with Graves' disease. Acta Endocrinol (Copenh) 99:379-385 (Pubitemid 12164997)
101. Rubio IG, Silva MN, Knobel M, Romão R, Possato R, Gebrin EM, Buchpiguel C, Medeiros-Neto G 2007 Peripheral blood levels of thyroglobulin mRNA and serum thyroglobulin concentrations after radioiodine ablation of multinodular goiter with or without pre-treatment with recombinant human thyrotropin. J Endocrinol Invest 30:535-540 (Pubitemid 47577804)
102. Benvenga S, Bartolone L, Squadrito S, Trimarchi F 1997 Thyroid hormone autoantibodies elicited by diagnostic fine needle biopsy. J Clin Endocrinol Metab 82:4217-4223 (Pubitemid 27525543)
103. Pacini F, Schlumberger M, Harmer C, Berg GG, Cohen O, Duntas L, Jamar F, Jarzab B, Limbert E, Lind P, Reiners C, Sanchez Franco F, Smit J, Wiersinga W 2005 Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report. Eur J Endocrinol 153:651-659 (Pubitemid 41672411)
104. Marquet PY, Daver A, Sapin R, Bridgi B, Muratet JP, Hartmann DJ, Paolucci F, Pau B 1996 Highly sensitive immunoradiometric assay for serum thyroglobulin with minimal interference from autoantibodies. Clin Chem 42:258-262 (Pubitemid 26063881)
105. Ruf J, Carayon P, Lissitzky S 1985 Various expressions of a unique anti-human thyroglobulin antibody repertoire in normal state and autoimmune disease. Eur J Immunol 15:268-272 (Pubitemid 15077962)
106. Bayer MF, Kriss JP 1979 Immunoradiometric assay for serum thyroglobulin: semiquantitative measurement of thyroglobulin in antithyroglobulin-positive sera. J Clin Endocrinol Metab 49:557-564 (Pubitemid 10231742)
107. Henniker AJ, Luttrell BM, Ward P, Stiel JN, Wilmshurst EG 1983 The measurement of antithyroglobulin autoantibodies in the presence of thyroglobulin. J Endocrinol Invest 6:277-285 (Pubitemid 14239996)
108. Feldt-Rasmussen U, Bech K, Date J 1979 Serum thyroglobulin in patients with toxic and non-toxic goitres compared to sex- and age-matched control subjects. Acta Endocrinol (Copenh) 91:264-270 (Pubitemid 9232137)
109. Gardner DF, Rothman J, Utiger RD 1979 Serum thyroglobulin in normal subjects and patients with hyperthyroidism due to Graves'disease: effects of T3, iodide, 131I and antithyroid drugs. Clin Endocrinol (Oxf) 11:585-594 (Pubitemid 10214353)
110. Prentice L, Kiso Y, Fukuma N, Horimoto M, Petersen V, Grennan F, Pegg C, Furmaniak J, Rees Smith B 1995 Monoclonal thyroglobulin autoantibodies: variable region analysis and epitope recognition. J Clin Endocrinol Metab 80:977-986
111. Schulz R, Bethäuser H, Stempka L, Heilig B, Moll A, Hüfner M 1989 Evidence for immunological differences between circulating and tissue-derived thyroglobulin in men. Eur J Clin Invest 19:459-463 (Pubitemid 19273684)
112. Feldt-Rasmussen U, Profilis C, Colinet E, Black E, Bornet H, Bourdoux P, Carayon P, Ericsson UB, Koutras DA, Lamas de Leon L, DeNayer P, Pacini F, Palumbo G, Santos A, Schlumberger M, Seidel C, Van Herle AJ, DeVijlder JJ 1996 Human thyroglobulin reference material (CRM 457) 2nd part: physicochemical characterization and certification. Ann Biol Clin (Paris) 54:343-348 (Pubitemid 27060141)
113. Ito N, Yokota M, Kawahara S, Nagaike C, Morimura Y, Hirota T, Matsunaga T 1995 Histochemical demonstration of different types of poly-N-acetyllactosamine structures in human thyroid neoplasms using lectins and endo-β- galactosidase digestion. Histochem J 27:620-629
114. Shimizu K, Nakamura K, Kobatake S, Satomura S, Maruyama M, Tajiri J, Kato R 2007 Discrimination of thyroglobulin from thyroid carcinoma tissue and that from benign thyroid tissues with use of competitive assay between lectin and anti-thyroglobulin antibody. Rinsho Byori 55:428-433
115. Spencer CA, LoPresti JS, Fatemi S, Nicoloff JT 1999 Detection of residual and recurrent differentiated thyroid carcinoma (DTC) by serum thyroglobulin (Tg) measurement. Thyroid 9:435-441 (Pubitemid 29244919)
116. McLachlan SM, Feldt-Rasmussen U, Young ET, Middleton SL, Dlichert-Toft M, Siersboek-Nielsen K, Date J, Carr D, Clark F, Rees Smith B 1987 IgG subclass distribution of thyroid autoantibodies: a 'fingerprint' of an individual's response to thyroglobulin and thyroid microsomal antigen. Clin Endocrinol (Oxf) 26:335-346 (Pubitemid 17018998)
117. Benvenga S, Burek CL, Talor M, Rose NR, Trimarchi F 2002 Heterogeneity of the thyroglobulin epitopes associated with circulating thyroid hormone autoantibodies in Hashimoto's thyroiditis and non-autoimmune thyroid diseases. J Endocrinol Invest 25:977-982 (Pubitemid 36113283)
118. Hoofnagle AN, Becker JO, Wener MH, Heinecke JW 2008 Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry. Clin Chem 54:1796-1804
119. Kohno Y, Tarutani O, Sakata S, Nakajima H 1985 Monoclonal antibodies to thyroglobulin elucidate differences in protein structure of thyroglobulin in healthy individuals and those with papillary adenocarcinoma. J Clin Endocrinol Metab 61:343-350 (Pubitemid 15000922)
120. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803 (Pubitemid 43997716)
121. Sapin R, d'Herbomez M, Gasser F, Meyer L, Schlienger JL 2003 Increased sensitivity of anewassay for anti-thyroglobulin antibody detection in patients with autoimmune thyroid disease. Clin Biochem 36:611-616 (Pubitemid 37434027)
122. Haapala AM, Soppi E, Mörsky P, Salmi J, Laine S, Mattila J 1995 Thyroid antibodies in association with thyroid malignancy II: qualitative properties of thyroglobulin antibodies. Scand J Clin Lab Invest 55:317-322
123. Gao Y, Yuan Z, Yu Y, Lu H 2007 Mutual interference between serum thyroglobulin and antithyroglobulin antibody in an automated chemiluminescent immunoassay. Clin Biochem 40:735-738 (Pubitemid 46829077)
124. de Micco C, Ruf J, Carayon P, Chrestian MA, Henry JF, Toga M 1987 Immunohistochemical study of thyroglobulin in thyroid carcinomas with monoclonal antibodies. Cancer 59:471-476 (Pubitemid 17002425)
125. Kim PS, Dunn AD, Dunn JT 1988 Altered immunoreactivity of thyroglobulin in thyroid disease. J Clin Endocrinol Metab 67:161-168
126. Ratcliffe JG, Ayoub LA, Pearson D 1981 The measurement of serum thyroglobulin in the presence of thyroglobulin antibodies. Clin Endocrinol (Oxf) 15:507-518